FULFARO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 10.931
EU - Europa 6.256
AS - Asia 5.063
SA - Sud America 699
AF - Africa 117
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.088
Nazione #
US - Stati Uniti d'America 10.781
SG - Singapore 1.848
RU - Federazione Russa 1.389
CN - Cina 1.317
IT - Italia 1.035
UA - Ucraina 822
DE - Germania 759
FI - Finlandia 625
HK - Hong Kong 559
BR - Brasile 556
VN - Vietnam 406
PL - Polonia 337
GB - Regno Unito 298
IE - Irlanda 295
FR - Francia 291
JP - Giappone 246
SE - Svezia 179
KR - Corea 116
IN - India 103
BD - Bangladesh 95
CA - Canada 60
TR - Turchia 60
AR - Argentina 59
IQ - Iraq 58
MX - Messico 42
NL - Olanda 41
BE - Belgio 35
UZ - Uzbekistan 35
ID - Indonesia 27
RO - Romania 27
ES - Italia 24
CI - Costa d'Avorio 23
MA - Marocco 23
AT - Austria 22
ZA - Sudafrica 21
NP - Nepal 20
EC - Ecuador 18
IR - Iran 18
VE - Venezuela 17
CH - Svizzera 16
PK - Pakistan 16
SA - Arabia Saudita 16
PH - Filippine 15
AE - Emirati Arabi Uniti 14
MY - Malesia 14
AU - Australia 13
CO - Colombia 12
KE - Kenya 12
PY - Paraguay 12
GR - Grecia 11
JM - Giamaica 10
KZ - Kazakistan 10
TN - Tunisia 10
CL - Cile 9
DZ - Algeria 9
AZ - Azerbaigian 8
JO - Giordania 8
LT - Lituania 7
PA - Panama 7
EG - Egitto 6
HN - Honduras 6
IL - Israele 6
LB - Libano 6
PE - Perù 6
TW - Taiwan 6
AL - Albania 5
AO - Angola 5
BH - Bahrain 5
EU - Europa 5
GE - Georgia 5
NI - Nicaragua 5
OM - Oman 5
BG - Bulgaria 4
BO - Bolivia 4
BY - Bielorussia 4
CR - Costa Rica 4
DK - Danimarca 4
MK - Macedonia 4
PS - Palestinian Territory 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
CY - Cipro 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
ET - Etiopia 2
LK - Sri Lanka 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
Totale 23.067
Città #
Ashburn 1.296
Singapore 1.194
Fairfield 1.187
Woodbridge 683
San Jose 643
Chandler 613
Hong Kong 543
Wilmington 521
Houston 501
Seattle 456
Jacksonville 431
Ann Arbor 386
Cambridge 329
Zgierz 292
Dublin 288
Moscow 251
Tokyo 240
Medford 223
Frankfurt am Main 221
Beijing 212
Santa Clara 207
Nanjing 175
Council Bluffs 161
Los Angeles 161
Palermo 144
Dallas 141
Princeton 141
Des Moines 136
Ho Chi Minh City 134
New York 132
Lauterbourg 129
Hefei 123
Boardman 116
Tulsa 109
Hanoi 107
Altamura 100
The Dalles 88
Lawrence 81
Ludwigshafen am Rhein 76
San Diego 73
Milan 69
Buffalo 68
Helsinki 65
Dearborn 59
Nanchang 54
São Paulo 51
Shenyang 50
Orem 48
Rome 48
Tianjin 45
Changsha 43
Chicago 42
Seongnam 42
Hebei 40
London 38
Seoul 36
Brussels 34
Nuremberg 30
Denver 28
Jiaxing 28
Jinan 28
Guangzhou 25
Warsaw 25
Atlanta 24
Montreal 24
Abidjan 23
City of London 22
Izmir 22
Baghdad 21
Kitzingen 20
Phoenix 20
Amsterdam 19
Cardiff 19
Chennai 19
Columbus 19
Falls Church 19
Poplar 19
Tashkent 19
Saint Petersburg 18
Berlin 17
Da Nang 17
Kumar 17
Munich 17
San Mateo 17
Stockholm 17
Verona 17
Zhengzhou 17
Boston 16
Rio de Janeiro 16
Hangzhou 15
Shanghai 15
Belo Horizonte 14
Haiphong 14
Bremen 13
Brooklyn 13
Dhaka 13
Johannesburg 13
Philadelphia 13
Curitiba 12
Kunming 12
Totale 14.682
Nome #
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study 363
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 337
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 319
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 316
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 291
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 282
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 275
Clinical presentation and treatment of gastrointestinal stromal tumors. 267
A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients 265
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 261
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 260
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 256
A case of squamocellular uterine cervix carcinoma metastatic to the skin with enterocutaneous fistula. 254
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 251
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 247
Surgical Treatment of Extravasation Injuries 246
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report 223
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 223
Isolated Metachronous Splenic Metastasis from Colon Cancer: Possible Explanations for This Rare Entity 222
USE OF HERBAL REMEDIES AMONG CANCER AND TRANSPLANT PATIENTS IN THE TOWN OF PALERMO, SICILY 218
Indagine sulla qualità di vita ansia e depressione in un gruppo di pazienti affette da carcinoma mammario 215
Γ δ T Cell-Based Immunotherapy in Melanoma: State of the Art 215
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 213
Treatment strategies for cancer patients with breakthrough pain. 213
Minor hepatic resection using heat coagulative necrosis. 210
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 208
Serum follistatin in patients with prostate cancer metastatic to the bone 206
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 205
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients 204
Bortezomib: a new pro-apoptotic agent in cancer treatment. 200
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 200
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. 199
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. 195
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. 194
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 192
The use of corticosteroids in home palliative care 192
Factors involved in gastrointestinal bleeding in advanced cancer patients followed at home 191
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 190
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation 189
Low morphine doses in opioid-naive cancer patients with pain. 188
World Health Organization guidelines for cancer pain: a reappraisal 187
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. 187
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 186
A phase II study of Oxaliplatin Capecitabine chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 184
LINEE GUIDA AIOM Trattamento e Prevenzione della Cachessia Neoplastica 184
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients 184
Carcinoma squamocellulare del pene localmente avanzato: associazione tra risposta clinica e modificazione dei livelli di ferritina sierica. 183
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? 183
Cardiotossicità e Cardioprotezione. 178
Detection and clinical relevance of free circulating tumor DNA in blood of patients with gastrointestinal cancer 177
Complicanze orali in pazienti affetti da carcinoma del cavo orale e sottoposti a radio e chemioterapia. Mucositi e xerostomia 174
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma 174
A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: Effects on dose-escalation and a pharmacoeconomic analysis 173
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 173
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 172
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 171
Opioid responsiveness-primary diagnosis relationship in advanced cancer patients followed at home 171
Management of painful bone metastases 169
Effective use of a sodium-hyaluronate spray formulation in oral mucositis 169
A randomized phase II study of estramustine phosphate versus estramustine phosphate plus etoposide in hormone refractory prostate cancer (HRPC). 168
A case report of inflammatory pseudotumor of the liver 167
Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion 164
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 160
Use of herbal products among cancer and transplanted patients in the town of Palermo,Sicily. 158
The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer. 157
Investigation of an opioid response categorization in advanced cancer patients 156
Studio di phase II: Docetaxel settimanale come seconda linea chemioterapia nel carcinoma prostatico avanzato. 154
The Use of Gemcitabine in heavily pretreted breast cancer patients 154
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer 154
The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results 154
Autoimmunity predicts prolonged survival in colon cancer patients undergoing GOLFIG biochemotherapy. 153
The use of somatostatin analogues in metastatic hormone refractory and chemo resistant prostate cancer with neuroendocrine differentiation. 151
Antiblastic drug combinations with ifosfamide: an update 150
Acrobat Swinger e altro 147
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway 147
The course of symptom frequency and intensity in advanced cancer patients followed at home 147
The impact of home palliative care on symptoms in advanced cancer patients 147
Weekly paclitaxel and Pegylated liposomal doxorubicin as first line treatment in metastatic breast cancer patients 147
The use of pilocarpine in opioid-induced xerostomia 146
Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment † 142
2001 Odissea nello Spazio 141
La terapia adiuvante nel carcinoma del colon: un update della lettaratura 140
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 140
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 139
Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis 139
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible 138
APOCALYPTO di Mel Gibson 138
Factors influencing the opioid response in advanced cancer patients with pain followed at home: The effects of age and gender 138
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 137
Apocalypse Now di Francis Ford Coppola 136
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 134
The role of bisphosphonates in the treatment of painful metastatic bone disease: A review of phase III trials 133
Opioid plasma concentration during switching from morphine to methadone: Preliminary data 133
2046 di Wong Kar Wai 132
Pain mechanisms involved and outcome in advanced cancer patients with possible indications for celiac plexus block and superior hypogastric plexus block 131
Role of pamidronate disodium in the treatment of metastatic bone disease 131
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. 129
Relationship between the thymidylate synthase, p53 levels with the treatment by Cyclophosphamide, Metotrexate, 5-Fluorouracil chemotherapy (CMF) versus Docetaxel (TXT) in the locally advanced carcinoma of breast. 128
Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients. 128
Gastrointestinal bleeding in advanced cancer patients 127
Totale 18.689
Categoria #
all - tutte 77.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021213 0 0 0 0 0 0 0 0 0 0 0 213
2021/20221.465 49 405 20 37 51 50 83 55 214 156 84 261
2022/20231.728 203 279 18 193 228 290 99 136 155 17 91 19
2023/2024864 56 135 63 52 76 150 120 39 15 12 14 132
2024/20252.298 52 133 87 242 100 61 186 209 127 250 302 549
2025/20268.605 583 252 544 670 716 1.222 1.160 859 671 1.506 247 175
Totale 23.456